SPHK1 and mesothelioma: Overexpression of SphK1 is linked to many cancer types, including prostate, colorectal, brain, breast, liver, mesothelioma, and other lung diseases [12, 15–21] and has been identified as oncogenic due to “gain of function” in preference to any identifiable mutations [22].